The effect of a multispecies probiotic on the intestinal microbiota and bowel movements in healthy volunteers taking the antibiotic amoxycillin

American Journal of Gastroenterology

Volumn 103, Issue 1, 2008, Pages 178-189

  Koning, Catherina J M ^a   Jonkers, Daisy M A E ^a   Stobberingh, Ellen E ^a   Mulder, Linda ^b   Rombouts, Frans M ^c   Stockbrügger, Reinhold W ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b WINCLOVE PROBIOTICS   (Netherlands)

^c WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; AMOXICILLIN; BETA GLUCOSIDASE; BUTYRIC ACID; CLOSTRIDIUM DIFFICILE TOXIN A; ECOLOGIC AAD; ENDOTOXIN; PLACEBO; PROBIOTIC AGENT; PROPIONIC ACID; SHORT CHAIN FATTY ACID; UNCLASSIFIED DRUG;

ABDOMINAL CRAMP; ADULT; ARTICLE; BACTERIAL VIABILITY; BACTERIUM CULTURE; BIFIDOBACTERIUM LONGUM; BLOATING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFECATION; DIARRHEA; DOUBLE BLIND PROCEDURE; ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; ENZYME ACTIVITY; FECES ANALYSIS; FEMALE; FLATULENCE; HUMAN; HUMAN EXPERIMENT; INTESTINE FLORA; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS RHAMNOSUS; MALE; MICROBIAL METABOLISM; NAUSEA; NORMAL HUMAN; PH MEASUREMENT; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SACCHAROMYCES BOULARDII; STATISTICAL ANALYSIS; VOLUNTEER;

ADOLESCENT; ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; BACTERIA; BETA-GLUCOSIDASE; COLONY COUNT, MICROBIAL; DEFECATION; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTESTINES; MALE; MIDDLE AGED; PROBIOTICS; PROGNOSIS; REFERENCE VALUES;

EID: 37849013482     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01547.x     Document Type: Article

References (80)

1. Bartlett JG. Antibiotic-associated diarrhea. Clin Infect Dis 1992 15 : 573 81.
2. McFarland LV. Epidemiology, risk factors and treatments for antibiotic-associated diarrhea. Dig Dis 1998 16 : 292 307.
3. McFarland LV. Epidemiology of infectious and iatrogenic nosocomial diarrhea in a cohort of general medicine patients. Am J Infect Control 1995 23 : 295 305.
4. Gustafsson A, Berstad A, Lund-Tonnesen S, et al. The effect of faecal enema on five microflora-associated characteristics in patients with antibiotic-associated diarrhoea. Scand J Gastroenterol 1999 34 : 580 6.
5. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994 330 : 257 62.
6. Aronsson B, Mollby R, Nord CE. Diagnosis and epidemiology of Clostridium difficile enterocolitis in Sweden. J Antimicrob Chemother 1984 14 (Suppl D 85 95.
7. Hogenauer C, Hammer HF, Krejs GJ, et al. Mechanisms and management of antibiotic-associated diarrhea. Clin Infect Dis 1998 27 : 702 10.
8. Beaugerie L, Petit JC. Microbial-gut interactions in health and disease. Antibiotic-associated diarrhoea. Best Pract Res Clin Gastroenterol 2004 18 : 337 52.
9. Van Vlem B, Vanholder R, De Paepe P, et al. Immunomodulating effects of antibiotics: Literature review. Infection 1996 24 : 275 91.
10. Levy SB. The 2000 Garrod lecture. Factors impacting on the problem of antibiotic resistance. J Antimicrob Chemother 2002 49 : 25 30.
11. De Giorgio R, Barbara G, Stanghellini V, et al. Diagnosis and therapy of irritable bowel syndrome. Aliment Pharmacol Ther 2004 20 (Suppl 2 10 22.
12. Madden JA, Plummer SF, Tang J, et al. Effect of probiotics on preventing disruption of the intestinal microflora following antibiotic therapy: A double-blind, placebo-controlled pilot study. Int Immunopharmacol 2005 5 : 1091 7.
13. McAuliffe OE, Klaenhammer TR. Genomic perspectives on probioitcs and the gastrointestinal microflora. In : Tannock GW, ed. Probiotics and prebiotics, where are we going? Norfolk : Caister Academic Press, 2002 : 263 309.
14. Gotz V, Romankiewicz JA, Moss J, et al. Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation. Am J Hosp Pharm 1979 36 : 754 7.
15. Surawicz CM, Elmer GW, Speelman P, et al. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: A prospective study. Gastroenterology 1989 96 : 981 8.
16. Wunderlich PF, Braun L, Fumagalli I, et al. Double-blind report on the efficacy of lactic acid-producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhoea and in the treatment of acute diarrhoea. J Int Med Res 1989 17 : 333 8.
17. Siitonen S, Vapaatalo H, Salminen S, et al. Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea. Ann Med 1990 22 : 57 9.
18. McFarland LV, Surawicz CM, Greenberg RN, et al. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am J Gastroenterol 1995 90 : 439 48.
19. Vanderhoof JA, Whitney DB, Antonson DL, et al. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 1999 135 : 564 8.
20. Armuzzi A, Cremonini F, Bartolozzi F, et al. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2001 15 : 163 9.
21. Arvola T, Laiho K, Torkkeli S, et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: A randomized study. Pediatrics 1999 104 : e64.
22. Adam J, Barret A, Barret-Bellet C. Esais cliniques controles en doubles insu de l'ultra-leur lyophyilisee. Etude multi-centrique par 25 medicines de 38 cas. Gaz Med Francaise 1977 84 : 2072 8.
23. Tankanow RM, Ross MB, Ertel IJ, et al. A double-blind, placebo-controlled study of the efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhea. DICP 1990 24 : 382 4.
24. Thomas MR, Litin SC, Osmon DR, et al. Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: A randomized, placebo-controlled trial. Mayo Clin Proc 2001 76 : 883 9.
25. Lewis SJ, Potts LF, Barry RE. The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients. J Infect 1998 36 : 171 4.
26. Cremonini F, Di Caro S, Nista EC, et al. Meta-analysis: The effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2002 16 : 1461 7.
27. D'Souza AL, Rajkumar C, Cooke J, et al. Probiotics in prevention of antibiotic associated diarrhoea: Meta-analysis. BMJ 2002 324 : 1361.
28. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006 101 : 812 22.
29. Orrhage K, Sjostedt S, Nord CE. Effect of supplements with lactic acid bacteria and oligofructose on the intestinal microflora during administration of cefpodoxime proxetil. J Antimicrob Chemother 2000 46 : 603 12.
30. Plummer SF, Garaiova I, Sarvotham T, et al. Effects of probiotics on the composition of the intestinal microbiota following antibiotic therapy. Int J Antimicrob Agents 2005 26 : 69 74.
31. Timmerman HM, Koning CJ, Mulder L, et al. Monostrain, multistrain and multispecies probiotics-A comparison of functionality and efficacy. Int J Food Microbiol 2004 96 : 219 33.
32. Ouwehand AC, Isolauri E, Kirjavainen PV, et al. The mucus binding of Bifidobacterium lactis Bb12 is enhanced in the presence of Lactobacillus GG and Lact. delbrueckii subsp. bulgaricus. Lett Appl Microbiol 2000 30 : 10 3.
33. Gomes AM, Malcata FX, Klaver FA. Growth enhancement of Bifidobacterium lactis Bo and Lactobacillus acidophilus Ki by milk hydrolyzates. J Dairy Sci 1998 81 : 2817 25.
34. O'Donnell LJ, Virjee J, Heaton KW. Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate. BMJ 1990 300 : 439 40.
35. Hartemink R, Domenech VR, Rombouts FM. LAMVAB-a new selective medium for the isolation of lactobacilli from faeces. J Microbiol Methods 1997 29 : 77 84.
36. Summanen P, Baron EJ, Citron DM, et al. Wadsworth anaerobic bacteriology manual, 5th Ed. Belmont, CA : Star Publishing Company0, 1993 : 168.
37. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing. J Clin Microbiol 1995 33 : 2233 9.
38. van den Braak N, van Belkum A, van Keulen M, et al. Molecular characterization of vancomycin-resistant enterococci from hospitalized patients and poultry products in The Netherlands. J Clin Microbiol 1998 36 : 1927 32.
39. Goossens D, Jonkers D, Russel M, et al. The effect of Lactobacillus plantarum 299v on the bacterial composition and metabolic activity in faeces of healthy volunteers: A placebo-controlled study on the onset and duration of effects. Aliment Pharmacol Ther 2003 18 : 495 505.
40. Bibiloni R, Fedorak RN, Tannock GW, et al. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 2005 100 : 1539 46.
41. Kim HJ, Camilleri M, McKinzie S, et al. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2003 17 : 895 904.
42. Mimura T, Rizzello F, Helwig U, et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004 53 : 108 14.
43. Goossens D, Jonkers D, Russel M, et al. Survival of the probiotic, L. plantarum 299v and its effects on the faecal bacterial flora, with and without gastric acid inhibition. Dig Liver Dis 2005 37 : 44 50.
44. Lund B, Edlund C, Barkholt L, et al. Impact on human intestinal microflora of an Enterococcus faecium probiotic and vancomycin. Scand J Infect Dis 2000 32 : 627 32.
45. Link-Amster H, Rochat F, Saudan KY, et al. Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol Med Microbiol 1994 10 : 55 63.
46. Tannock GW, Munro K, Harmsen HJ, et al. Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Appl Environ Microbiol 2000 66 : 2578 88.
47. Brismar B, Edlund C, Nord CE. Impact of cefpodoxime proxetil and amoxicillin on the normal oral and intestinal microflora. Eur J Clin Microbiol Infect Dis 1993 12 : 714 9.
48. Christensson B, Nilsson-Ehle I, Ljungberg B, et al. A randomized multi-centre trial to compare the influence of cefaclor and amoxycillin on the colonization resistance of the digestive tract in patients with lower respiratory tract infection. Infection 1991 19 : 208 15.
49. Gipponi M, Sciutto C, Accornero L, et al. Assessing modifications of the intestinal bacterial flora in patients on long-term oral treatment with bacampicillin or amoxicillin: A random study. Chemioterapia 1985 4 : 214 7.
50. Leigh DA. Pharmacology and toxicological studies with amoxycillin, talampicillin and ampicillin and a clinical trial of parenteral amoxycillin in serious hospital infections. Drugs Exp Clin Res 1979 5 : 129 39.
51. Poutanen SM, Simor AE. Clostridium difficile-associated diarrhea in adults. CMAJ 2004 171 : 51 8.
52. McFarland LV, Mulligan ME, Kwok RY, et al. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989 320 : 204 10.
53. Rivera EV, Woods S. Prevalence of asymptomatic Clostridium difficile colonization in a nursing home population: A cross-sectional study. J Gend Specif Med 2003 6 : 27 30.
54. Johnson S, Gerding DN, Olson MM, et al. Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. Am J Med 1990 88 : 137 40.
55. Goldin BR. In situ bacterial metabolism and colon mutagens. Annu Rev Microbiol 1986 40 : 367 93.
56. Rowland I. Metabolic interaction in the gut. In : Fuller R, ed. Probiotics: The scientific basis. London : Chapman and Hall 1992 : 29 53.
57. Cole CB, Fuller R, Mallet AK, et al. The influence of the host on expression of intestinal microbial enzyme activities involved in metabolism of foreign compounds. J Appl Bacteriol 1985 59 : 549 53.
58. Gadelle D, Raibaud P, Sacquet E. beta-Glucuronidase activities of intestinal bacteria determined both in vitro and in vivo in gnotobiotic rats. Appl Environ Microbiol 1985 49 : 682 5.
59. Goldin BR, Swenson L, Dwyer J, et al. Effect of diet and Lactobacillus acidophilus supplements on human fecal bacterial enzymes. J Natl Cancer Inst 1980 64 : 255 61.
60. Marteau P, Pochart P, Flourie B, et al. Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic flora in humans. Am J Clin Nutr 1990 52 : 685 8.
61. Spanhaak S, Havenaar R, Schaafsma G. The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. Eur J Clin Nutr 1998 52 : 899 907.
62. Goris H, de Boer F, Van Der Waaij D. Kinetics of endotoxin release by Gram-negative bacteria in the intestinal tract of mice during oral administration of bacitracin and during in vitro growth. Scand J Infect Dis 1988 20 : 213 9.
63. Holzheimer RG. Antibiotic induced endotoxin release and clinical sepsis: A review. J Chemother 2001 13 : 159 72.
64. Hurley JC. Endotoxemia: Methods of detection and clinical correlates. Clin Microbiol Rev 1995 8 : 268 92.
65. Hurley JC. Antibiotic-induced release of endotoxin. A therapeutic paradox. Drug Saf 1995 12 : 183 95.
66. Llopis M, Antolin M, Guarner F, et al. Mucosal colonisation with Lactobacillus casei mitigates barrier injury induced by exposure to trinitronbenzene sulphonic acid. Gut 2005 54 : 955 9.
67. Madsen K, Cornish A, Soper P, et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001 121 : 580 91.
68. Van Saene JJM, Stoutenbeek CC, Van Saene HK, et al. Reduction of the inestinal endotoxin pool by three different SDD regimens in human volunteers. J Endotoxin Res 1996 3 : 337 43.
69. Cook SI, Sellin JH. Review article: Short chain fatty acids in health and disease. Aliment Pharmacol Ther 1998 12 : 499 507.
70. Gustafsson A, Lund-Tonnesen S, Berstad A, et al. Faecal short-chain fatty acids in patients with antibiotic-associated diarrhoea, before and after faecal enema treatment. Scand J Gastroenterol 1998 33 : 721 7.
71. Meijer-Severs GJ, Van Santen E, Meijer BC. Short-chain fatty acid and organic acid concentrations in feces of healthy human volunteers and their correlations with anaerobe cultural counts during systemic ceftriaxone administration. Scand J Gastroenterol 1990 25 : 698 704.
72. Fukuda M, Kanauchi O, Araki Y, et al. Prebiotic treatment of experimental colitis with germinated barley foodstuff: A comparison with probiotic or antibiotic treatment. Int J Mol Med 2002 9 : 65 70.
73. Hove H, Nordgaard-Andersen I, Mortensen PB. Effect of lactic acid bacteria on the intestinal production of lactate and short-chain fatty acids, and the absorption of lactose. Am J Clin Nutr 1994 59 : 74 9.
74. Rochet V, Rigottier-Gois L, Sutren M, et al. Effects of orally administered Lactobacillus casei DN-114 001 on the composition or activities of the dominant faecal microbiota in healthy humans. Br J Nutr 2006 95 : 421 9.
75. Johansson ML, Nobaek S, Berggren A, et al. Survival of Lactobacillus plantarum DSM 9843 (299v), and effect on the short-chain fatty acid content of faeces after ingestion of a rose-hip drink with fermented oats. Int J Food Microbiol 1998 42 : 29 38.
76. Schneider SM, Girard-Pipau F, Filippi J, et al. Effects of Saccharomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition. World J Gastroenterol 2005 11 : 6165 9.
77. Bourriaud C, Robins RJ, Martin L, et al. Lactate is mainly fermented to butyrate by human intestinal microfloras but inter-individual variation is evident. J Appl Microbiol 2005 99 : 201 12.
78. Louis P, Scott KP, Duncan SH, et al. Understanding the effects of diet on bacterial metabolism in the large intestine. J Appl Microbiol 2007 102 : 1197 208.
79. Wong JM, de Souza R, Kendall CW, et al. Colonic health: Fermentation and short chain fatty acids. J Clin Gastroenterol 2006 40 : 235 43.
80. Macfarlane GT, Macfarlane S. Human colonic microbiota: Ecology, physiology and metabolic potential of intestinal bacteria. Scand J Gastroenterol Suppl 1997 222 : 3 9.